DENTSPLY SIRONA Inc.
XRAY
Positions held
Your positionsXRAY isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-08.
- DENTSPLY SIRONA Inc. operates in a competitive healthcare sector, focusing on innovative dental products that cater to a growing global market.
- Revenue increased by 2% compared to the prior quarter, reaching $898 million.
- Gross margin improved to 54.9%, up from 48.5% in the previous quarter.
- The company has a negative profit margin of -14.99%, indicating ongoing financial struggles.
- Net income for the last quarter was $37 million, but the previous quarter reported a loss of $10 million.
- The stock has a 'Strong Sell' signal with a score of -24.00, reflecting negative market trends.
Fundamentals
| Market cap | $1.73B | Enterprise value | $3.82B | Trailing P/E | — | Forward P/E | 5.81 |
| PEG | 0.55 | Price / book | 1.32 | Beta | 0.88 | Dividend yield | 0.00% |
| Revenue growth | -4.1% | Earnings growth | — | Gross margin | 49.5% | Operating margin | 9.2% |
| Profit margin | -15.0% | ROE | -33.0% | ROA | 2.0% | Debt / equity | 1.72 |
| Current ratio | 1.63 | Free cash flow | $141.62M | Analyst recommendation | hold | Mean target | $13.40 |
| 52w high | $14.76 | 52w low | $8.38 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $898M | $880M | $961M | $904M | $936M | — |
| Op margin | 9.2% | 3.4% | 2.6% | 5.1% | 11.6% | — |
| Net income | $37.0M | -$10.0M | -$146M | -$427M | -$45.0M | — |
| Gross margin | 54.9% | 48.5% | 46.1% | 48.8% | 52.4% | — |
| Gross profit | $493M | $427M | $443M | $441M | $490M | — |
| Operating income | $83.0M | $30.0M | $25.0M | $46.0M | $109M | — |
- Revenue +2% vs prior quarter ($898M vs $880M).
- Gross margin 54.9% (was 48.5% prior quarter).
- Operating margin expanded to 9.2%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $3.7B | $3.8B | $4.0B | $3.9B | — |
| Op margin | 6.8% | 5.0% | 7.3% | 9.3% | — |
| Net income | -$598M | -$910M | -$132M | -$950M | — |
| Gross margin | 50.0% | 51.6% | 52.6% | 54.2% | — |
| Gross profit | $1.8B | $2.0B | $2.1B | $2.1B | — |
| Operating income | $252M | $188M | $289M | $364M | — |
Headlines — watch
• [WARN · legal] 3 Stocks Under $10 Walking a Fine Line
News
2026-10-08 · DENTSPLY SIRONA (XRAY) Tests Its Reset Story After Midwest Dental Expansion
2026-10-07 · Wellspect HealthCare Announces U.S. Medicare Reimbursement Access for Surity™ Urinary Management Portfolio
2026-10-06 · Dentsply Sirona Expands Distribution Collaboration With Midwest Dental
2026-10-06 · Dentsply Sirona Continues North American Commercial Expansion with Midwest Dental Agreement
2026-09-28 · 3 Stocks Under $10 Walking a Fine Line
2026-09-25 · Q2 Rundown: Dentsply Sirona (NASDAQ:XRAY) Vs Other Dental Equipment & Technology Stocks
2026-09-23 · 1 Value Stock with Impressive Fundamentals and 2 Facing Headwinds
2026-09-17 · Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio for Now
2026-09-11 · 3 Russell 2000 Stocks We Steer Clear Of
Price (daily)
Full chart · RSI · MACD · patterns